Cargando…
Whey protein isolate inhibits hepatic FGF21 production, which precedes weight gain, hyperinsulinemia and hyperglycemia in mice fed a high-fat diet
Insufficient expression of hepatic fibroblast growth factor 21 (FGF21) and stromal cell-derived factor 2 like 1 (Sdf2l1) reportedly leads to insulin resistance and hepatosteatosis in obesity and type 2 diabetes. On the other hand, increased expression of hepatic serotonin receptor 2a (htr2a) in diet...
Autores principales: | Nonogaki, Katsunori, Kaji, Takao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519058/ https://www.ncbi.nlm.nih.gov/pubmed/32978487 http://dx.doi.org/10.1038/s41598-020-72975-8 |
Ejemplares similares
-
Ingestion of whey protein and β-conglycinin exerts opposite effects on intestinal FGF15 and serotonin secretion in mice
por: Nonogaki, Katsunori, et al.
Publicado: (2023) -
Pharmacologic inhibition of serotonin htr2b ameliorates hyperglycemia and the altered expression of hepatic FGF21, Sdf2l1, and htr2a in db/db mice and KKA(y) mice
por: Nonogaki, Katsunori, et al.
Publicado: (2020) -
Liraglutide, a GLP-1 Receptor Agonist, Which Decreases Hypothalamic 5-HT2A Receptor Expression, Reduces Appetite and Body Weight Independently of Serotonin Synthesis in Mice
por: Nonogaki, Katsunori, et al.
Publicado: (2018) -
Whey Protein Reduces Early Life Weight Gain in Mice Fed a High-Fat Diet
por: Tranberg, Britt, et al.
Publicado: (2013) -
Protective Effect of Vanillic Acid against Hyperinsulinemia, Hyperglycemia and Hyperlipidemia via Alleviating Hepatic Insulin Resistance and Inflammation in High-Fat Diet (HFD)-Fed Rats
por: Chang, Wen-Chang, et al.
Publicado: (2015)